In December, Sens. Elizabeth Warren, D-Massachusetts, and Peter Welch, D-Vermont, sent a letter to Pfizer admonishing the company for a proposed increase in the price of …

In a split showing for cancer powerhouse Merck, its immunotherapy Keytruda continued a losing streak in prostate cancer but chalked up a win to pressure an industry-first …

Vir Biotechnology is tapping a veteran pharma dealmaker—and one of 2021’s Fiercest Women in Life Sciences—to helm the ship as the company’s long-time captain George …

Abzena, a CDMO specializing in the development and manufacture of antibody-drug conjugates, has laid off 66 employees in San Diego, according to a Worker Adjustment …

The nonprofit public health advocacy group the Physicians Committee has issued a formal complaint over allegations that Novo Nordisk paid for a promotional segment on …

Once again, biopharma companies offered hefty discounts to secure national reimbursement in China in the hopes that wider coverage in a fast-growing pharmaceutical market can …

Setting its sights on production and R&D expansions, GenScript’s biologics subsidiary ProBio notched its third fundraising round in less than two years. The CDMO’s $224 …

In the months since the Supreme Court reversed the landmark Roe vs. Wade decision, the discourse surrounding abortions has reached a fever pitch. Now, after anti-abortion groups …

After gaining FDA approvals in 2015 and 2019 for Lonsurf, Servier and Taiho Oncology are due for a third nod this year for the cancer …

Throughout the whirlwind COVID-19 vaccine rollouts in the U.S., federal officials have kept a close eye on reports of adverse events. Now, after tracking potential …